KeyCorp Lowers UnitedHealth Group (NYSE:UNH) Price Target to $450.00

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective reduced by KeyCorp from $575.00 to $450.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. KeyCorp's price target suggests a potential upside of 54.51% from the stock's current price.

Other equities research analysts have also issued research reports about the stock. HSBC restated a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Mizuho increased their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Six analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $486.00.

UnitedHealth Group Price Performance

NYSE UNH traded up $16.89 on Wednesday, reaching $291.24. The company's stock had a trading volume of 70,463,502 shares, compared to its average volume of 5,875,758. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm's 50 day moving average is $470.82 and its two-hundred day moving average is $513.60. UnitedHealth Group has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a market cap of $264.20 billion, a PE ratio of 18.79, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by company insiders.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new stake in UnitedHealth Group during the first quarter worth $3,846,764,000. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $1,914,740,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.